Travma Sonrası Stres Bozukluğu Hastalarında İnterlökin-4, İnterlökin-17, İnterferon-Gama ve Beyaz Kan Hücre Düzeyleri ile Sosyodemografik Özelliklerin İncelenmesi

Öz

Amaç: Bu çalışmada, travma sonrası stres bozukluğu (TSSB) tanısı alan bireylerde interlökin-4 (IL-4), interlökin-17(IL-17), interferon gama (IFN-γ) ve beyaz kan hücre düzeylerinin incelenmesi, bu biyobelirteçlerle ile sosyodemografik ve klinik özellikler arasındaki ilişkilerin değerlendirilmesi amaçlanmıştır. Yöntemler: Çalışmaya 6 Şubat 2023 Kahramanmaraş merkezli depremlerin ardından 01.06.2023 ile 31.01.2024 tarihleri arasında Dicle Üniversitesi Tıp Fakültesi Psikiyatri Polikliniği’ne başvuran, DSM-5-TR kriterlerine göre TSSB tanısı konulan 18-65 yaş arası 53 hasta, kontrol grubu olarak yaş ile cinsiyet açısından eşleştirilmiş ve benzer sosyodemografik özelliklere sahip olan herhangi bir psikiyatrik hastalığı olmayan 53 sağlıklı birey dahil edilmiştir. Katılımcılardan alınan kan örneklerinde IL-4, IL-17 ve IFN-γ düzeyleri ELISA (Enzyme-Linked Immunosorbent Assay) yöntemiyle üretici firmanın protokollerine uygun olarak ticari kitler kullanılarak ölçülmüştür (Sunred Biotechnology Company, Çin). WBC düzeyleri Sysmex XN-1000 marka tam kan sayımı cihazıyla (Sysmex Corporation, Japonya) analiz edilmiştir. Tüm katılımcılara sosyodemografik veri formu, Klinik Global İzlenim Ölçeği (CGI), Travma Sonrası Stres Bozukluğu Kısa Ölçeği (TSSB-KÖ), Hamilton Anksiyete Değerlendirme Ölçeği (HAM-A) ve Hamilton Depresyon Değerlendirme Ölçeği (HAM-D) uygulanmıştır. Bulgular: Vaka ve kontrol grupları arasında hemogram parametreleri ile IL-4, IL-17 ve IFN-γ düzeylerinde istatistiksel olarak anlamlı fark bulunmamıştır. Ancak TSSB’li bireylerde eğitim süresi, medeni durum, çocuk sahibi olma, çalışma durumu, gelir durumu ve evi hasar gören yakını bulunma gibi sosyodemografik özellikler ile klinik ölçek puanları açısından istatistiksel olarak fark bulunmuştur. Sonuç: Bu çalışma ile deprem sonrası TSSB’de sosyoekonomik faktörlerin, yakın çevredeki hasar düzeyinin, eşlik eden depresyon ve anksiyete belirtilerinin ilişkileri ortaya konmuştur.

Anahtar Kelimeler

• Travma sonrası stres bozukluğu
• İnterlökin-4
• İnterlökin-17
• İnterferon gama
• Sosyodemografik özellikler

Investigation of the Relationship Between Interleukin-4, Interleukin-17, Interferon-Gamma, And white Blood Cell (Wbc) Levels and Sociodemographic Characteristics in Patients with Posttraumatic Stress Disorder

Öz

Objective: This study aimed to investigate the levels of interleukin-4 (IL-4), interleukin-17 (IL-17), interferon-gamma (IFN-γ), and white blood cells (WBC) in individuals diagnosed with post-traumatic stress disorder (PTSD) and to evaluate the relationships between these biomarkers and sociodemographic as well as clinical characteristics. Methods: The study included 53 patients aged between 18 and 65 years who were diagnosed with post-traumatic stress disorder (PTSD) according to DSM-5-TR criteria and who applied to the Psychiatry Outpatient Clinic of Dicle University Faculty of Medicine between June 1, 2023 and January 31, 2024, after the February 6, 2023 Kahramanmaraş-centered earthquakes. The control group comprised 53 healthy individuals with no history of psychiatric illness, matched to the patient group by age and sex and with comparable sociodemographic characteristics. Serum levels of IL-4, IL-17, and IFN-γ were measured using the ELISA (Enzyme-Linked Immunosorbent Assay) method with commercial kits according to the manufacturer’s protocols (Sunred Biological Technology Co., Ltd., China). WBC levels were analyzed using a Sysmex XN-1000 automated hematology analyzer (Sysmex Corporation, Japan). All participants were assessed using a sociodemographic data form, the Clinical Global Impression Scale (CGI), the Posttraumatic Stress Disorder Short Scale (PTSD-SS), the Hamilton Anxiety Rating Scale (HAM-A), and the Hamilton Depression Rating Scale (HAM-D). Results: No statistically significant differences were found between the patient and control groups in terms of hemogram parameters and IL-4, IL-17, and IFN-γ levels. However, statistically significant differences were found in sociodemographic characteristics such as educational level, marital status, having children, employment status, income level, and having relatives whose homes were damaged, as well as in clinical scale scores among individuals with PTSD. Conclusion: This study demonstrated the associations between socioeconomic factors, the degree of environmental damage, and accompanying depressive and anxiety symptoms in post-earthquake PTSD.

Anahtar Kelimeler

• Post-traumatic stress disorder
• Interleukin-4; Interleukin-17; Interferon-gamma
• Sociodemographic characteristics

Kaynakça

1. 1. Miao XR, Chen QB, Wei K, et al. Posttraumatic stress disorder: from diagnosis to prevention. Mil Med Res. 2018;5(1):32.
2. 2. Çoban D, Gündoğmuş İ. Comparison of posttraumatic stress disorder symptom profile according to sexual and non-sexual trauma types. Anatol J Psychiatry. 2019; 20:470–76.
3. 3. Başoğlu M, Şalcıoğlu E, Livanou M. Traumatic stress responses in earthquake survivors in Turkey. J Trauma Stress. 2002;15(4):269–76.
4. 4. Tural Ü, Coşkun B, Önder E, et al. Psychological consequences of the 1999 earthquake in Turkey. J Trauma Stress. 2004;17(6):451–59.
5. 5. Tekin A, Yetkin Tekin A, Göçüm E, et al. Posttraumatic stress disorder and related risk factors among earthquake survivors after earthquakes in Turkey: 1-year follow-up study. Psychol Trauma. Theory, Research, Practice, and Policy. 2025; 17(6), 1369–76
6. 6. Yılmazer E. Psychological distress, resilience, and well-being among survivors of the 2023 Kahramanmaraş earthquakes: a multi-site crosssectional study. Front Psychol. 2025;16:1730083.
7. 7. Bolu A, Taner Ö, Aydemir ME. Post-traumatic stress disorder. Anatolian Journal of Clinical Investigation . Anatol J Clin Investig. 2014;8(2):101–8.
8. 8. Hori H, Kim Y. Inflammation and post-traumatic stress disorder. Psychiatry Clin Neurosci. 2019;73(4):143-53.

9. 9. Toft H, Bramness JG, Lien L, et al. PTSD patients show increasing cytokine levels during treatment despite reduced psychological distress. Neuropsychiatr Dis Treat. 2018;14:2367–78.
10. 10. Guo M, Liu T, Guo JC, et al. Study on serum cytokine levels in posttraumatic stress disorder patients. Asian Pac J Trop Med. 2012;5(4):323–5.
11. 11. Eraly SA, Nievergelt CM, Maihofer AX, et al. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry. 2014;71(4):423–31.
12. 12. Skarpa I, Rubesa G, Moro L, et al. Changes of cytolytic cells and perforin expression in patients with posttraumatic stress disorder. Croat Med J. 2001;42(5):551–5.
13. 13. Lauten TH, Natour T, Case AJ. Innate and adaptive immune system consequences of posttraumatic stress disorder. Auton Neurosci. 2024; 252:103159.
14. 14. LeBeau RT, Mischel ER, Resnick HS, et al. Dimensional assessment of posttraumatic stress disorder in DSM-5. Psychiatry Res. 2014;218(1-2):143–7.
15. 15. Evren C, Dalbudak E, Aydemir Ö, et al. Psychometric properties of the Turkish PTSD-Short Scale in a sample of undergraduate students. Psychiatry Clin Psychopharmacol. 2016;26(3):294–302.
16. 16. Guy W. ECDEU assessment manual for psychopharmacology. Revised ed. Rockville (MD):National Institute of Mental Health; 1976.
17. 17. Zağlı N, Aydemir Ö, Danacı AE, et al. Clinical global impression scale: reliability and validity study of the Turkish version. Turk Psikiyatri Derg. 2003;14(2):93–99. 18. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–55.
18. 19. Yazıcı MK, Demir B, Tanrıverdi N, et al. Hamilton anxiety rating scale: interrater reliability and validity study. Turk Psikiyatri Derg. 1998;9(2):114–117.
19. 20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62.
20. 21. Akdemir A, Örsel SD, Dağ İ, et al. Hamilton Depresyon Derecelendirme Ölçeği’nin geçerliğigüvenirliği ve klinikte kullanımı. Psikiyatri Psikol Psikofarmakol Derg. 1996;4(4):251–9.
21. 22. Yimer GM, Adem YF, Haile Y. Determinants of post-traumatic stress disorder among survivors of road traffic accidents in Ethiopia. BMC Psychiatry. 2023;23(1):218.
22. 23. Tang B, Deng Q, Glik D, et al. A meta-analysis of risk factors for post-traumatic stress disorder after earthquakes. Int J Environ Res Public Health. 2017;14(12):1537.
23. 24. Tesfaye AH, Sendekie AK, Kabito GG, et al. Posttraumatic stress disorder among internally displaced persons in Africa: a systematic review and meta-analysis. PLoS One. 2024;19(4):e0300894.
24. 25. Taha PH, Taib NI, Sulaiman HM. Posttraumatic stress disorder correlates among internally displaced Yazidi population. BMC Psychiatry. 2021;21(1):290.
25. 26. Fel S, Jurek K, Lenart-Kłoś K. Relationship between socio-demographic factors and posttraumatic stress disorder. Int J Environ Res Public Health. 2022;19(5):2720.
26. 27. Ali M, Mutavi T, Mburu JM, et al. Prevalence of posttraumatic stress disorder and depression among internally displaced persons in Somalia. Neuropsychiatr Dis Treat. 2023; 19:469–78.
27. 28. Makango B, Alemu ZA, Solomon T, et al. Prevalence and factors associated with posttraumatic stress disorder among internally displaced people in Ethiopia. BMC Psychiatry. 2023;23(1):81.
28. 29. Powell TM, Shin OJ, Li SJ, et al. Post-traumatic stress, social and physical health among Syrian refugees. PLoS One. 2020;15(10): e0241036.
29. 30. Sakuma A, Takahashi Y, Ueda I, et al. Posttraumatic stress disorder and depression among disaster relief workers. BMC Psychiatry. 2015;15(1):58.
30. 31. Montazeri A, Baradaran H, Omidvari S, et al. Psychological distress among Bam earthquake survivors in Iran. BMC Public Health. 2005;5(1):4.
31. 32. Hoppen TH, Priebe S, Vetter I, et al. Global burden of post-traumatic stress disorder and major depression in war-affected countries. BMJ Glob Health. 2021;6(7): e006303.
32. 33. Mgoqi-Mbalo N, Zhang M, Ntuli S. Risk factors for PTSD and depression in female survivors of rape. Psychol Trauma. 2017;9(3):301–08.
33. 34. Yang JJ, Jiang W. Immune biomarker alterations in post-traumatic stress disorder: a systematic review and meta-analysis. J Affect Disord. 2020 May;268:39–46.